Literature DB >> 28233412

A QCM-D and SAXS Study of the Interaction of Functionalised Lyotropic Liquid Crystalline Lipid Nanoparticles with siRNA.

Behnoosh Tajik-Ahmadabad1,2, Adam Mechler3, Benjamin W Muir2, Keith McLean2, Tracey M Hinton4, Frances Separovic1, Anastasios Polyzos1,2.   

Abstract

Biophysical studies were undertaken to investigate the binding and release of short interfering ribonucleic acid (siRNA) from lyotropic liquid crystalline lipid nanoparticles (LNPs) by using a quartz crystal microbalance (QCM). These carriers are based on phytantriol (Phy) and the cationic lipid DOTAP (1,2-dioleoyloxy-3-(trimethylammonium)propane). The nonlamellar phase LNPs were tethered to the surface of the QCM chip for analysis based on biotin-neutravidin binding, which enabled the controlled deposition of siRNA-LNP complexes with different lipid/siRNA charge ratios on a QCM-D crystal sensor. The binding and release of biomolecules such as siRNA from LNPs was demonstrated to be reliably characterised by this technique. Essential physicochemical parameters of the cationic LNP/siRNA lipoplexes-such as particle size, lyotropic phase behaviour, cytotoxicity, gene silencing and uptake efficiency-were also assessed. The SAXS data show that when the pH was lowered to 5.5 the structure of the lipoplexes did not change, thus indicating that the acidic conditions of the endosome were not a significant factor in the release of siRNA from the cationic lipidic carriers.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cubosomes; drug delivery; lipids; mesophases; siRNA

Mesh:

Substances:

Year:  2017        PMID: 28233412     DOI: 10.1002/cbic.201600613

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

Review 1.  Cubosomes: The Next Generation of Smart Lipid Nanoparticles?

Authors:  Hanna M G Barriga; Margaret N Holme; Molly M Stevens
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-26       Impact factor: 15.336

Review 2.  Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.

Authors:  Yuan Zhang; Juhura G Almazi; Hui Xin Ong; Matt D Johansen; Scott Ledger; Daniela Traini; Philip M Hansbro; Anthony D Kelleher; Chantelle L Ahlenstiel
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

3.  Easy colorimetric detection of gadolinium ions based on gold nanoparticles: key role of phosphine-sulfonate ligands.

Authors:  Marjorie Yon; Claire Pibourret; Jean-Daniel Marty; Diana Ciuculescu-Pradines
Journal:  Nanoscale Adv       Date:  2020-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.